Status:
UNKNOWN
Bryophyllum vs. Nifedipine
Lead Sponsor:
Weleda AG
Conditions:
Tocolysis
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
PHASE3
Brief Summary
In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.
Eligibility Criteria
Inclusion
- Female
Exclusion
- Bishop Score \> 5
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2008
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00391339
Start Date
November 1 2006
End Date
October 1 2008
Last Update
October 23 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics, University of Zuerich
Zurich, Canton of Zurich, Switzerland, 8091